S. Ofner et al., SAR OF 2-BENZYL-4-AMINOPIPERIDINES - CGP-49823, AN ORALLY AND CENTRALLY ACTIVE NONPEPTIDE NK1 ANTAGONIST, Bioorganic & medicinal chemistry letters, 6(14), 1996, pp. 1623-1628
Novel 2-benzyl-4-aminopiperidines have been shown to be potent and sel
ective antagonists at the NK1 receptor. Some compounds of this series,
e.g. CGP 49823 (2), show CNS activity after oral administration. Copy
right (C) 1996 Elsevier Science Ltd